oral glutamine supplement inhibits ascites formation in peritoneal carcinomatosis mouse model
Clicks: 444
ID: 128575
2013
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
76.7
/100
444 views
321 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #6 of 188 articles by views in colloids and surfaces a: physicochemical and engineering aspects
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 188 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Background. Peritoneal carcinomatosis (PC) accompanied with ascites formation causes several distressing symptoms, resulting in poor quality of life. Methods. Twenty BALB/c nude mice generated by direct orthotopic injection of human pancreatic cancer PANC-1 cells were randomized to receive either a stock laboratory diet or a stock diet supplemented with glutamine. Half of the mice were sacrificed at day 76 to measure the amount of ascitic fluid and pancreatic tumor volume. The remaining mice were subject to survival analysis. Serum albumin levels were estimated every 2 weeks. Results. At day 76, the average amount of ascitic fluid measured in the control group was 1.2±0.3 mL compared to 0.5±0.5 mL from the glutamine-supplemented mice (P=0.045). The volume of pancreatic tumor was 2.60±0.8 cm3 in the control group and 1.98±1.3 cm3 in glutamine-supplemented mice (P=0.39). The mean survival time of glutamine-supplemented mice was prolonged from 87±4 to 101±2 days (P=0.0024). Mean serum albumin levels were higher in the glutamine-supplemented group. Conclusions. This preclinical study showed that oral supplementation of glutamine may provide ascites-reducing activity in pancreatic cancer patients with PC, via a cell-mediated immunity-independent mechanism.
| Reference Key |
chen2013gastroenterologyoral
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Ming-Jen Chen;Tsang-En Wang;Shu-Jung Tsai;Ching-Chung Lin;Chia-Yuan Liu;Horng-Yuan Wang;Shou-Chuan Shih;Yu-Jen Chen |
| Journal | colloids and surfaces a: physicochemical and engineering aspects |
| Year | 2013 |
| DOI |
10.1155/2013/814054
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.